We read with interest the description by Cervantes and the International Working Group for Myelofibrosis Research and Treatment (IWG-MRT) of a new prognostic index for patients with primary myelofibrosis. 1 This system, based on 5 adverse characteristics, identified 4 prognostic subgroups. Using the c index of Harrell, the authors stated that the IWG-MRT scores have higher discriminating power than previous scores. However, the use of this index on the sample for which the classification score has been tailor-made is seldom of interest because it estimates probability of concordance between predicted and observed responses. 2 The estimation of separation parameter D would better assess whether increasing complexity results in a useful increase in discriminating power. 3 Using the bootstrap resampling method, we compared the separation parameters 3 Although the present study, as previous reports, does not meet criteria for external validation, the results observed with a prolonged follow-up do not support a higher discriminating power of the IWG-MRT score. Moreover, they support the use of a simplified Lille scoring system, combining intermediate-and high-risk patients in a single category. Given the simplicity of Lille system, further evaluations are required to compare the usefulness of these tools for clinical practice. 
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